Page 197 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

The Clinical Approach to Patients with Vasculitis 173

[27] Weymann, S., Yonekawa, Y., Khan, N., et al. Severe arterial occlusive disorder and
brachysyndactyly in a boy: a further case of Grange syndrome? Am. J. Med. Genet.
2001; 99:190-195.

[28] Calabrese, L. H. Evidence-based clinical science and art in the diagnosis of central
nervous system vasculitis. Presse Med. 2013; 42:600-602.

[29] Calabrese, L. H., Dodick, D. W., Schwedt, T. J., et al. Narrative review: reversible
cerebral vasoconstriction syndromes. Ann. Intern. Med. 2007; 146:34-44.

[30] Pipitone, N., Paxxola, G., Muratore, F., et al. Assessment of vasculitis extent and
severity. Presse Med. 2013; 42:588-589.

[31] Blockmans, D., Bley, T., Schmidt, W. Imaging for large-vessel vasculitis. Curr. Opin.
Rheumatol. 2009; 21:19-28.

[32] Hoffman, G. S., Kerr, G. S., Leavitt, R. Y., et al. Wegener?s granulomatosis: an analysis
of 158 patients. Ann. Intern. Med. 1992; 116:488-498.

[33] Schnabel, A., Holl-Ulrich, K., Dalhoff, K., et al. Efficacy of transbronchial biopsy in
pulmonary vaculitides. Eur. Respir. J. 1997; 10:2738-2743.

[34] Basu, N., Watts, R., Bajema, I., et al. EULAR points to consider in the development of
classification and diagnostic criteria in systemic vasculitis. Ann. Rheum. Dis. 2010; 69:
1744-1750.

[35] Pagnoux, C., Mahr, A., Cohen, P., et al. Presentation and outcome of gastrointestinal
involvement in systemic necrotizing vasculitides: analysis of 62 patients with
polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss
syndrome, or rheumatoid arthritis-associated vasculitis. Medicine 2005; 84:115-128.

[36] Salvarani, C., Cantini, F., Boiardi, L., et al. Polymyalgia rheumatic and giant cell
arteritis. N. Engl. J. Med. 2002; 347:261-271.

[37] Mukhtyar, C., Guillevin, L., Cid, M. C., et al. EULAR recommendations for the
management of large vessel vasculitis. Ann. Rheum. Dis. 2009; 68:318-323.

[38] Younge, B. E., Cook, B. R., Bartley, G. B., et al. Initiation of glucocorticoid therapy:
before or after temporal artery biopsy? Mayo Clin. Proc. 2004; 79:483-491.

[39] Achkar, A. A., Lie, J. T., Hunder, G. G., et al. How does previous corticosteroid
treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann. Intern. Med.
1994; 120:987-992.

[40] Droz, N., Gilardin, L., Cacoub, P., et al. Kinetic profiles and management of hepatitis B
virus reactivation in patients with immune-mediated inflammatory diseases. Arthritis
Care Res. 2013; 65:1504-1514.

[41] Matulis, G., Juni, P., Villager, P. M., et al. Detection of latent tuberculosis in
immunosuppressed patients with autoimmune diseases: performance of a
Mycobacterium tuberculosis antigen-specific interferon ? assay. Ann. Rheum. Dis.
2008; 67:84-90.

[42] Karadag, O., Aksu, K., Sahin, A., et al. Assessment of latent tuberculosis infection in
Takayasu arteritis with tuberculin skin test and Quantiferon-TB Gold test. Rheumatol.
Int. 2010; 30:1483-1487.

[43] Falagas, M. E., Manta, K. G., Betsi, G. I., et al. Infection-related morbidity and
mortality in patients with connective tissue diseases: a systematic review. Clin.
Rheumatol. 2007; 26:663-670.

[44] http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6104a9.htm.

Complimentary Contributor Copy